M11.05
Hydroxyapatite deposition disease, hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Hydroxyapatite Deposition Disease (HADD) of the hip is a condition characterized by the abnormal buildup of calcium deposits, specifically hydroxyapatite crystals, in the soft tissues surrounding the hip joint. This buildup can lead to inflammation, joint pain, and limited mobility. Although it can be diagnosed at any age, HADD most commonly affects middle-aged and older adults. Understanding this condition can help in managing symptoms effectively and seeking appropriate medical care.
Causes & Symptoms
Clinical Causes: Degenerative changes in tendons and soft tissues Repeated trauma or injury to the hip area Aging, which can alter tissue metabolism Genetic predisposition affecting calcium metabolism Underlying metabolic disorders that influence calcium deposit formation
Key Symptoms: Severe, aching pain in the hip, especially during movement or activity Tenderness and swelling around the hip joint Reduced range of motion and stiffness in the hip Pain that may radiate to the buttocks or thigh Possible crepitus or a clicking sensation during movement
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and imaging studies. Medical professionals typically perform a physical exam to assess pain response, tenderness, and joint mobility. Imaging techniques are crucial for confirming the presence of calcium deposits. These may include: - **X-rays:** The primary tool to visualize calcium deposits in the soft tissues around the hip. - **Ultrasound:** Useful for detecting deposits and assessing the extent of inflammation. - **MRI scans:** May be used if other conditions need to be ruled out or to evaluate soft tissue involvement more precisely. Laboratory tests are usually not specific for HADD but may be done to rule out other causes of joint pain or calcium metabolism disorders.
Treatment Protocols: Managing Hydroxyapatite Deposition Disease generally involves a combination of conservative treatments aimed at reducing pain and inflammation: - **Rest and activity modification:** Avoiding activities that exacerbate symptoms. - **Non-steroidal anti-inflammatory drugs (NSAIDs):** Medications such as ibuprofen or naproxen to alleviate pain and swelling. - **Physical therapy:** Specific exercises to improve joint flexibility and strength. - **Local interventions:** Corticosteroid injections into the affected area can provide significant relief. - **Extracorporeal shock wave therapy (ESWT):** Considered in some cases to help break down calcium deposits. - **Surgical removal:** In persistent or severe cases where conservative measures fail, minimally invasive procedures or surgery may be necessary to remove calcium deposits. It is important for individuals with this condition to work closely with healthcare professionals for tailored treatment plans to manage symptoms effectively.
Clinical Advice & FAQs
Billing Guidance
Is M11.05 a billable ICD-10 code?
Yes, M11.05 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.05?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease, hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
